Impact of COVID-19 on quality of life in people with epilepsy, and a multinational comparison of clinical and psychological impacts

Koh, May-Yi and Lim, Kheng-Seang and Fong, Si Lei and Khor, Si Bao and Tan, Chong Tin (2021) Impact of COVID-19 on quality of life in people with epilepsy, and a multinational comparison of clinical and psychological impacts. Epilepsy & Behavior, 117. ISSN 1525-5050, DOI https://doi.org/10.1016/j.yebeh.2021.107849.

Full text not available from this repository.

Abstract

Background: This study aimed to determine the relationship among the clinical, logistic, and psychological impacts of COVID-19 on people with epilepsy (PWE), and the impact of COVID-19 on the quality of life. Method: This is a cross-sectional anonymized web-based study on PWE, using an online questionnaire to assess the clinical, logistic, and psychological impacts of COVID-19, including Hospital Anxiety Depression Scale (HADS) and Quality of Life in Epilepsy Inventory (QOLIE-31). Result: 461 patients were recruited, with a mean age of 39.21 +/- 15.88 years, majority female (50.1%), with focal epilepsy (54.0%), and experienced seizures at least once yearly (62.5%). There were 13.0% experienced seizure worsening during COVID-19 period, which were associated with baseline seizures frequency >= 1 per month (32.0% vs. 6.2%, p < 0.001), worries of seizure worsening (18.0% vs. 10.9%, p < 0.001), difficulty to go emergency unit (24.4% vs. 10.4%, p < 0.001), AEDs ran out of stock (23.2% vs. 11.6%, p < 0.05), self-adjustment of AED dosages (26.4% vs. 11.3%, p < 0.001), inadequate sleep (22.4% vs. 9.2%, p < 0.001), and stress (23.4% vs.10.1%, p < 0.01). Participants experiencing seizure worsening reported greater anxiety (8.10 +/- 5.011 vs. 4.84 +/- 3.989, p < 0.001) and depression (6.05 +/- 3.868 vs. 3.86 +/- 3.589, p < 0.001). Logistic regression showed baseline seizures frequency >1 per month (OR, 14.10) followed by anxiety (OR, 3.90), inadequate sleep (OR, 0.37), and treated in UMMC (OR, 0.31) as the predictors for seizure worsening during COVID-19 period. Poorer total QOLIE-31 score was noted in those with seizure worsening (48.01 +/- 13.040 vs. 62.15 +/- 15.222, p < 0.001). Stepwise regression highlighted depression as the main negative predictor for quality of life (beta = -0.372, p < 0.001), followed by anxiety (b = -0.345, p < 0.001). Conclusion: A significant number of PWE experienced seizure worsening during COVID-19 period, which was related to the clinical, logistic, and psychological factors. Quality of life was affected by the seizure worsening and the psychological stress. (C) 2021 Elsevier Inc. All rights reserved.

Item Type: Article
Funders: University of Malaya Faculty of Medicine Postgraduate Scheme, Impact Oriented Interdisciplinary Research Grant (IIRG) Programme (IIRG003A2020HWB)
Uncontrolled Keywords: COVID-19; Epilepsy; Seizure control; Quality of life; Depression; Anxiety
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine
Depositing User: Ms Zaharah Ramly
Date Deposited: 16 Jun 2022 07:52
Last Modified: 16 Jun 2022 07:52
URI: http://eprints.um.edu.my/id/eprint/27936

Actions (login required)

View Item View Item